Connect Biopharma Holdings Ltd. (CNTB)
0.6541
-0.01
(-1.68%)
USD |
NASDAQ |
Nov 13, 10:26
Connect Biopharma Holdings Free Cash Flow (Quarterly) : -16.19M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.19M |
| March 31, 2026 | -16.00M |
| December 31, 2025 | -11.62M |
| Date | Value |
|---|---|
| September 30, 2025 | -17.73M |
| June 30, 2025 | -12.96M |
| March 31, 2025 | -10.04M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Anavex Life Sciences Corp. | -9.096M |
| Vaxcyte, Inc. | -229.04M |
| Foghorn Therapeutics, Inc. | -18.25M |
| Caribou Biosciences, Inc. | -22.54M |
| Arrowhead Pharmaceuticals, Inc. | -181.32M |